2023 Q3 Form 10-Q Financial Statement

#000149315223029537 Filed on August 21, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $41.88K $35.14K $20.69K
YoY Change -16.09% 69.83% -42.16%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $140.4K $4.356K $523.3K
YoY Change -65.91% -99.17% 982.23%
% of Gross Profit
Research & Development $0.00 $16.54K
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $140.4K -$1.439M $539.8K
YoY Change -65.91% -366.65% 1016.44%
Operating Profit $1.475M -$519.1K
YoY Change -384.04% 4025.01%
Interest Expense -$51.74K -$36.57K -$30.91K
YoY Change 69.86% 18.31% 148.07%
% of Operating Profit -2.48%
Other Income/Expense, Net -$30.71K -$36.20K -$148.2K
YoY Change -74.51% -75.58% 1134.54%
Pretax Income -$180.9K $1.438M -$667.4K
YoY Change -64.72% -315.53% 2613.91%
Income Tax
% Of Pretax Income
Net Earnings -$180.9K $1.438M -$667.4K
YoY Change -64.72% -315.53% 2613.8%
Net Earnings / Revenue -431.97% 4093.72% -3225.63%
Basic Earnings Per Share $0.17 -$0.09
Diluted Earnings Per Share -$0.02 $0.16 -$90.56K
COMMON SHARES
Basic Shares Outstanding 8.152M shares 8.313M shares 7.369M shares
Diluted Shares Outstanding 9.195M shares 7.369M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $40.83K $1.830K $72.68K
YoY Change 12.23% -97.48% 78.05%
Cash & Equivalents $40.83K $1.832K $72.68K
Short-Term Investments
Other Short-Term Assets $0.00 $0.00
YoY Change -100.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $128.4K $114.8K $199.5K
YoY Change -93.9% -42.48% 10.59%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $128.4K $114.8K $199.5K
Total Long-Term Assets $0.00 $0.00
Total Assets $128.4K $114.8K $199.5K
YoY Change -93.9% -42.48% 10.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $67.39K $110.5K $2.300K
YoY Change 94.83% 4705.65% -42.5%
Accrued Expenses $379.1K $350.8K $228.1K
YoY Change 46.91% 53.8% 16550.36%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $741.0K $0.00
YoY Change
Long-Term Debt Due $1.211M $470.0K $890.9K
YoY Change 20.65% -47.24% 8808.6%
Total Short-Term Liabilities $1.658M $1.672M $1.121M
YoY Change 27.86% 49.15% 6318.23%
LONG-TERM LIABILITIES
Long-Term Debt $10.00K $10.00K $10.00K
YoY Change 0.0% 0.0% -98.65%
Other Long-Term Liabilities $2.720K $2.570K $1.970K
YoY Change 28.3% 30.46% -98.73%
Total Long-Term Liabilities $12.72K $12.57K $11.97K
YoY Change 4.95% 5.01% -98.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.658M $1.672M $1.121M
Total Long-Term Liabilities $12.72K $12.57K $11.97K
Total Liabilities $1.670M $1.685M $1.133M
YoY Change 27.65% 48.69% 24.03%
SHAREHOLDERS EQUITY
Retained Earnings -$9.604M -$7.077M -$6.296M
YoY Change 41.05% 12.4%
Common Stock $8.251K $8.151K $7.599K
YoY Change 2.38% 7.26%
Preferred Stock
YoY Change
Treasury Stock (at cost) $45.00K
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.542M -$1.570M -$933.7K
YoY Change
Total Liabilities & Shareholders Equity $128.4K $114.8K $199.5K
YoY Change -93.9% -42.48% 10.59%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$180.9K $1.438M -$667.4K
YoY Change -64.72% -315.53% 2613.8%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$161.0K -$740.00 -$213.7K
YoY Change 229.85% -99.65% -2832.61%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 200.0K 0.000 254.9K
YoY Change 1500.0% -100.0%
NET CHANGE
Cash From Operating Activities -161.0K -740.0 -213.7K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 200.0K 0.000 254.9K
Net Change In Cash 39.00K -740.0 41.19K
YoY Change -207.41% -101.8% 426.73%
FREE CASH FLOW
Cash From Operating Activities -$161.0K -$740.00 -$213.7K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001536089
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
usd
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
CY2023Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
VRVR Net Reversal Of Amortization Of Prepaid Stockbased Compensation
NetReversalOfAmortizationOfPrepaidStockbasedCompensation
usd
VRVR Increase Decrease In Accrued Interest Related Parties
IncreaseDecreaseInAccruedInterestRelatedParties
usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
VRVR Debt Discount On Notes Payable
DebtDiscountOnNotesPayable
usd
us-gaap Stock Issued1
StockIssued1
usd
VRVR Common Stock Issued For Prepaid Expenses
CommonStockIssuedForPrepaidExpenses
usd
VRVR Redemption Of Common Stock And Warrants Issued For Prepaid Services
RedemptionOfCommonStockAndWarrantsIssuedForPrepaidServices
usd
VRVR Warrants Issued For Prepaid Expenses
WarrantsIssuedForPrepaidExpenses
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
VIRTUAL INTERACTIVE TECHNOLOGIES CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
36-4752858
dei Entity Address Address Line1
EntityAddressAddressLine1
600 17th Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2800 South
dei Entity Address City Or Town
EntityAddressCityOrTown
Denver
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80202
dei City Area Code
CityAreaCode
(303)
dei Local Phone Number
LocalPhoneNumber
228-7120
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8151534 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1832 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36378 usd
CY2023Q2 VRVR Royalty Receivable Current
RoyaltyReceivableCurrent
82214 usd
CY2022Q3 VRVR Royalty Receivable Current
RoyaltyReceivableCurrent
83644 usd
CY2023Q2 us-gaap Interest Receivable Current
InterestReceivableCurrent
5708 usd
CY2022Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
4586 usd
CY2023Q2 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
25000 usd
CY2022Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
25000 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1956215 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
114754 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
2105823 usd
CY2023Q2 us-gaap Assets
Assets
114754 usd
CY2022Q3 us-gaap Assets
Assets
2105823 usd
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
110529 usd
CY2022Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
34591 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
350843 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
34129 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
470000 usd
CY2022Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
262686 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1672402 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1296376 usd
CY2023Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
10000 usd
CY2022Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
10000 usd
CY2023Q2 VRVR Interest Payable Non Current
InterestPayableNonCurrent
2569 usd
CY2022Q3 VRVR Interest Payable Non Current
InterestPayableNonCurrent
2121 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
12569 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
12121 usd
CY2023Q2 us-gaap Liabilities
Liabilities
1684971 usd
CY2022Q3 us-gaap Liabilities
Liabilities
1308497 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8842784 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8151534 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8100284 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8059034 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
8151 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
8059 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5495390 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7595246 usd
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
691250 shares
CY2022Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
41250 shares
CY2023Q2 VRVR Treasury Stock Cumulative Cost
TreasuryStockCumulativeCost
0 usd
CY2022Q3 VRVR Treasury Stock Cumulative Cost
TreasuryStockCumulativeCost
0 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7076964 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6809185 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1570217 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
797326 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
114754 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2105823 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35136 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20689 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
110733 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
80719 usd
CY2023Q2 VRVR Professional Fees Expenses
ProfessionalFeesExpenses
-1480843 usd
CY2022Q2 VRVR Professional Fees Expenses
ProfessionalFeesExpenses
254364 usd
VRVR Professional Fees Expenses
ProfessionalFeesExpenses
-28426 usd
VRVR Professional Fees Expenses
ProfessionalFeesExpenses
486057 usd
CY2023Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
37056 usd
CY2022Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
255550 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
85098 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
314485 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16539 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16539 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4356 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13368 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9520 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
36337 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
-1439431 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
539821 usd
us-gaap Operating Expenses
OperatingExpenses
66192 usd
us-gaap Operating Expenses
OperatingExpenses
853418 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1474567 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-519132 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
44541 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-772699 usd
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
374 usd
CY2022Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
449 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1122 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1347 usd
CY2022Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
117764 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
207314 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
310203 usd
CY2023Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
36148 usd
CY2022Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
16741 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
78085 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
32784 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-422 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-79 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-406 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-650 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-36196 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-148219 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-312320 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-384663 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1438371 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-667351 usd
us-gaap Net Income Loss
NetIncomeLoss
-267779 usd
us-gaap Net Income Loss
NetIncomeLoss
-1157362 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8320435 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7369188 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8266314 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7083577 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9195031 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7369188 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9140910 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7083577 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-232740 usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
79500 usd
CY2023Q2 VRVR Redemption Of Stock Issued For Prepaid Services
RedemptionOfStockIssuedForPrepaidServices
-1243000 usd
CY2023Q2 VRVR Adjustments To Additional Paid In Capital Redemption Of Warrants Issued For Prepaid Services
AdjustmentsToAdditionalPaidInCapitalRedemptionOfWarrantsIssuedForPrepaidServices
-1649518 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
37170 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1438371 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1570217 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-798134 usd
CY2022Q2 VRVR Stock Issued During Period Value Commitment Fee Debt Discount On Note Payable
StockIssuedDuringPeriodValueCommitmentFeeDebtDiscountOnNotePayable
206250 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
37500 usd
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
288000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-667351 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-933735 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
797326 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
94375 usd
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
37170 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
298000 usd
VRVR Redemption Of Stock Issued For Prepaid Services
RedemptionOfStockIssuedForPrepaidServices
-1243000 usd
VRVR Adjustments To Additional Paid In Capital Redemption Of Warrants Issued For Prepaid Services
AdjustmentsToAdditionalPaidInCapitalRedemptionOfWarrantsIssuedForPrepaidServices
-1649518 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
363209 usd
us-gaap Net Income Loss
NetIncomeLoss
-267779 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1570217 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-607373 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
381000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
37500 usd
VRVR Stock Issued During Period Value Commitment Fee Debt Discount On Note Payable
StockIssuedDuringPeriodValueCommitmentFeeDebtDiscountOnNotePayable
412500 usd
us-gaap Net Income Loss
NetIncomeLoss
-1157362 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-933735 usd
us-gaap Net Income Loss
NetIncomeLoss
-267779 usd
us-gaap Net Income Loss
NetIncomeLoss
-1157362 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
94375 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
381000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
207314 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
310203 usd
VRVR Net Reversal Of Amortization Of Prepaid Stockbased Compensation
NetReversalOfAmortizationOfPrepaidStockbasedCompensation
-275094 usd
VRVR Options Issued For Services
OptionsIssuedForServices
37170 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1122 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1347 usd
VRVR Increase Decrease In Royalty Receivables
IncreaseDecreaseInRoyaltyReceivables
-1430 usd
VRVR Increase Decrease In Royalty Receivables
IncreaseDecreaseInRoyaltyReceivables
-26202 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
75938 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-34714 usd
VRVR Increase Decrease In Accrued Interest Related Parties
IncreaseDecreaseInAccruedInterestRelatedParties
42372 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
93222 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
18016 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34546 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-415630 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
434750 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
37500 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
235000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
237250 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-34546 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-178380 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
36378 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
251064 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1832 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
72684 usd
us-gaap Interest Paid Net
InterestPaidNet
14769 usd
VRVR Debt Discount On Notes Payable
DebtDiscountOnNotesPayable
35250 usd
us-gaap Stock Issued1
StockIssued1
412500 usd
VRVR Common Stock Issued For Prepaid Expenses
CommonStockIssuedForPrepaidExpenses
298000 usd
VRVR Redemption Of Common Stock And Warrants Issued For Prepaid Services
RedemptionOfCommonStockAndWarrantsIssuedForPrepaidServices
2892518 usd
VRVR Warrants Issued For Prepaid Expenses
WarrantsIssuedForPrepaidExpenses
363209 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84D_eus-gaap--UseOfEstimates_znTq5jPCroV7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline"><span id="xdx_86A_zewEeO87Fzf">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimated.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p>
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q3 VRVR Number Of Shares Treasury And Warrants Cancelled
NumberOfSharesTreasuryAndWarrantsCancelled
450000 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
0 usd
VRVR Reverse Recognized Expense
ReverseRecognizedExpense
578712 usd
CY2023Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
45000 usd
CY2022Q1 us-gaap Stock Issued1
StockIssued1
235000 usd
CY2022Q1 us-gaap Share Price
SharePrice
1.25
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-422 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-79 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-406 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-650 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zCt6v2Or3xN1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline"><span id="xdx_86D_zFDJzcv7oYMc">Concentration of Credit Risk</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Some of our US dollar balances are held in a Bermuda bank that is not insured. As of June 30, 2023 and September 30, 2022, uninsured deposits in the Bermuda bank totaled $<span id="xdx_907_eus-gaap--CashUninsuredAmount_iI_c20230630__dei--LegalEntityAxis__custom--BermudaBankMember_zFA55w4zPiDk" title="Cash, uninsured deposits">250</span> and $<span id="xdx_901_eus-gaap--CashUninsuredAmount_iI_c20220930__dei--LegalEntityAxis__custom--BermudaBankMember_z7GEvAc1zTo7" title="Cash, uninsured deposits">20,495</span>, respectively. Our management believes that the financial institution is financially sound, and the risk of loss is low. The Company is in the process of migrating all of its banking to the institutions in the United States, which are insured by the FDIC up to $<span id="xdx_90E_eus-gaap--CashFDICInsuredAmount_iI_c20230630__srt--RangeAxis__srt--MaximumMember_z5GL39PIMEpl" title="Cash, FDIC insured amount">250,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p>
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35136 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20689 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
110733 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
80719 usd
CY2023Q2 VRVR Royalty Receivable Current
RoyaltyReceivableCurrent
82214 usd
CY2022Q3 VRVR Royalty Receivable Current
RoyaltyReceivableCurrent
83644 usd
CY2022Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
41250 shares
CY2022Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
0 usd
CY2023Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
200000 shares
CY2023Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
0 usd
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
691250 shares
CY2023Q2 us-gaap Treasury Stock Preferred Shares
TreasuryStockPreferredShares
691250 shares
CY2022Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
41250 shares
CY2022Q3 us-gaap Treasury Stock Preferred Shares
TreasuryStockPreferredShares
41250 shares
CY2023Q2 us-gaap Treasury Stock Carrying Basis
TreasuryStockCarryingBasis
0 usd
CY2022Q3 us-gaap Treasury Stock Carrying Basis
TreasuryStockCarryingBasis
0 usd
CY2022Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
41250 shares
CY2023Q2 VRVR Common Stock Capital Share Value Reserved For Future Issuance
CommonStockCapitalShareValueReservedForFutureIssuance
799978 usd

Files In Submission

Name View Source Status
0001493152-23-029537-index-headers.html Edgar Link pending
0001493152-23-029537-index.html Edgar Link pending
0001493152-23-029537.txt Edgar Link pending
0001493152-23-029537-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vrvr-20230630.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
vrvr-20230630_def.xml Edgar Link unprocessable
vrvr-20230630_lab.xml Edgar Link unprocessable
vrvr-20230630_cal.xml Edgar Link unprocessable
vrvr-20230630_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed